The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(Z)-N-{4-[(E)-2-(4-Chloro-phenyl)-vinyl]-phenyl}-2-cyano-3-cyclopropyl-3-hydroxy-acrylamide ID: ALA2111978
Max Phase: Preclinical
Molecular Formula: C21H17ClN2O2
Molecular Weight: 364.83
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: N#C/C(C(=O)Nc1ccc(/C=C\c2ccc(Cl)cc2)cc1)=C(/O)C1CC1
Standard InChI: InChI=1S/C21H17ClN2O2/c22-17-9-3-14(4-10-17)1-2-15-5-11-18(12-6-15)24-21(26)19(13-23)20(25)16-7-8-16/h1-6,9-12,16,25H,7-8H2,(H,24,26)/b2-1-,20-19-
Standard InChI Key: YNTMYIJMGKWPBD-SKSIYUIESA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
2.3319 -8.4831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7456 -7.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7489 -9.1991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3374 -9.9119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5177 -8.4882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3321 -7.0528 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.6856 -8.4830 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9217 -10.6318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7472 -10.6237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5708 -3.4835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9824 -4.1944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5669 -7.7657 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7436 -6.3400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5703 -9.1981 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7478 -3.4835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5708 -4.9072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0974 -3.4835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2744 -3.4835 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.5686 -6.3411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3338 -5.6281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9843 -5.6211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3362 -2.7685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3362 -4.1944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7495 -4.9082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5090 -4.1944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5090 -2.7685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 2 0
4 3 1 0
5 1 1 0
6 2 1 0
7 5 3 0
8 4 1 0
9 4 1 0
10 11 2 0
11 16 1 0
12 2 2 0
13 6 1 0
14 3 1 0
15 10 1 0
16 24 1 0
17 25 1 0
18 17 1 0
19 13 2 0
20 13 1 0
21 19 1 0
22 15 2 0
23 15 1 0
24 20 2 0
25 23 2 0
26 22 1 0
8 9 1 0
21 16 2 0
26 17 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 364.83Molecular Weight (Monoisotopic): 364.0979AlogP: 5.19#Rotatable Bonds: 5Polar Surface Area: 73.12Molecular Species: ACIDHBA: 3HBD: 2#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 5.90CX Basic pKa: ┄CX LogP: 4.63CX LogD: 3.12Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.33Np Likeness Score: -1.03
References 1. Kuo EA, Hambleton PT, Kay DP, Evans PL, Matharu SS, Little E, McDowall N, Jones CB, Hedgecock CJ, Yea CM, Chan AW, Hairsine PW, Ager IR, Tully WR, Williamson RA, Westwood R.. (1996) Synthesis, structure-activity relationships, and pharmacokinetic properties of dihydroorotate dehydrogenase inhibitors: 2-cyano-3-cyclopropyl-3-hydroxy-N-[3'-methyl-4'-(trifluoromethyl)phenyl ] propenamide and related compounds., 39 (23): [PMID:8917650 ] [10.1021/jm9604437 ]